Park Medi World Limited targets 6,590 beds by December 2028
Key highlights
- Park Medi plans to add 2,980 beds, from 3,610 in March 2026 to 6,590 by December 2028.
- Park Medi’s FY’27 schedule adds 1,430 beds and projects total capacity of 5,040 beds by March 2027.
- Kanpur and Gorakhpur account for 700 beds under Park Medi’s disclosed O&M model.
- Park Medi reported Rs 29.50 crore in fixed deposits and plans to use internal accruals and debt for growth.
powered by IRIS

Park Medi World Limited plans to expand from 3,610 beds in March 2026 to 6,590 beds by December 2028, an addition of 2,980 beds or about 83%. Park Medi’s published schedule calls for 1,430 beds to be added in FY’27, followed by projects in Uttar Pradesh, Haryana and other North Indian markets.
Know Park Medi World inside out
Results, valuation, peers and who's buying, in one view.
How will Park Medi reach 6,590 beds by December 2028?
Park Medi plans to reach 6,590 beds through 2,250 greenfield beds, 3,890 acquisition-category beds and 450 expansion beds by December 2028. The 2,980-bed increase compares with 3,610 beds in March 2026, while the presentation labels the March 2027, March 2028 and December 2028 figures as projected.
The schedule shows the fastest increase in FY’27, when capacity is projected to rise by 1,430 beds to 5,040 by March 2027. It then calls for a further 1,000 beds by March 2028 and 550 beds in the nine months to December 2028, taking the total increase since March 2026 to 83%.
Park Medi’s mix changes over the plan period because acquisition-category capacity rises by 1,380 beds, ahead of the 1,150-bed increase in greenfield capacity and the 450-bed increase from expansions. Between March 2028 and December 2028, acquisition and expansion capacity remain at 3,890 and 450 beds respectively, while greenfield capacity rises by 550 beds to 2,250.
Which projects are scheduled to add 1,430 beds in FY’27?
Park Medi lists six FY’27 additions totalling 1,430 beds, taking planned capacity from 3,610 beds at the start of FY’27 to 5,040 beds by March 2027. The projects include commissioned and launched hospitals in Q1 and Q2 FY’27, a December 2026 commissioning, and three Q4 FY’27 facilities.
The 350-bed Panchkula Hospital was commissioned on 10 April 2026, followed by the 330-bed Rudrapur Hospital, launched on 2 August 2026. Park Medi acquired Rudrapur’s The Medicity for Rs 177 crore and describes it as accredited by the National Accreditation Board for Hospitals and Healthcare Providers, or NABH; the company says the launch extended its presence to six states.
The 150-bed Mehar Hospital in Zirakpur is scheduled for commissioning in the first week of December 2026 and was acquired for about Rs 107 crore. Park Medi says Panchkula and Mehar strengthen its Tricity cluster, while the three facilities added through Q2 FY’27 bring capacity to 4,440 beds under the published schedule.
The Q4 FY’27 projects are 100-bed Park Platinum in Palam Vihar, Gurugram, 200-bed Febris Hospital in Narela, Delhi, and 300-bed Kanpur Hospital. Febris was acquired under the Insolvency and Bankruptcy Code in December 2025 for Rs 50.68 crore, while Kanpur is Park Medi’s first operations-and-maintenance, or O&M, asset and its second hospital in Uttar Pradesh after Agra.
Got a follow-up? Ask IRIS
What capacity additions are planned after FY’27?
Park Medi’s named projects after FY’27 include a 400-bed Gorakhpur O&M asset, 350 beds of expansion in Mohali and Ambala, a 250-bed Rohtak greenfield hospital and a 550-bed Prayagraj greenfield lease project. These disclosed projects align with the move from 5,040 beds in March 2027 to 6,590 beds in December 2028.
Gorakhpur is scheduled for April 2027 as a 400-bed acquisition-O&M project. Mohali is scheduled to add 150 beds in September 2027, taking capacity from 350 to 500 beds, while Ambala is planned to add 200 beds in October 2027, increasing capacity from 250 to 450 beds.
Rohtak is scheduled as a 250-bed greenfield project in January 2028. Prayagraj, scheduled for December 2028, is the largest named later-stage project at 550 beds under a greenfield lease model; that figure matches the increase in greenfield beds from 1,700 in March 2028 to 2,250 in December 2028.
Park Medi also classifies Park Platinum as a 100-bed expansion from 225 to 325 beds in its longer-term capacity list, while its FY’27 growth page describes a 100-bed Q4 FY’27 commissioning. The capacity table includes 100 expansion beds by March 2027, and the Mohali and Ambala additions bring cumulative expansion beds to 450 by March 2028.
Why is Park Medi using acquisitions, expansions and O&M assets?
Park Medi says its growth model combines greenfield projects, brownfield expansion, strategic acquisitions and O&M arrangements in North Indian clusters. By December 2028, the acquisition category is projected to be the largest at 3,890 beds, compared with 2,250 greenfield beds and 450 expansion beds.
The two disclosed O&M facilities are Kanpur, with 300 beds scheduled in Q4 FY’27, and Gorakhpur, with 400 beds scheduled for April 2027. Together they account for 700 beds, or about 23% of the 2,980 planned additions, and management says O&M contracts and partnerships can support faster ramp-up with lower upfront capital intensity.
The brownfield programme comprises 100 beds at Park Platinum, 150 beds at Mohali and 200 beds at Ambala. Park Medi says brownfield additions can improve asset utilisation, while its cluster format is intended to support capital-expenditure and operating-expenditure efficiency; it does not provide project-level cost or return targets.
How does Park Medi plan to fund its bed expansion?
Park Medi says it plans to fund expansion to 6,590 beds by calendar year 2028 through a mix of internal accruals and debt. The presentation reports Rs 29.50 crore in fixed deposits and says the company has headroom to raise debt, but does not disclose a total expansion budget or funding allocation for individual hospitals.
Management also reports promoter holding of about 82.9% and says holding can be diluted to the regulatory threshold of about 75%, allowing for an equity raise if required. The presentation further cites capacity to raise capital for unidentified acquisitions, which is an option rather than a disclosed financing commitment.
Park Medi attributes its H1 FY’27 operating momentum to higher patient volumes and average revenue per occupied bed, or ARPOB, and describes H1 FY’27 as its best six-month revenue period. It does not disclose numerical revenue, margin, occupancy or ARPOB targets linked to the 6,590-bed plan.
Conclusion
Park Medi’s plan would add 2,980 beds between March 2026 and December 2028, with 1,430 beds scheduled in FY’27 and acquisition-category capacity remaining the largest component at 3,890 beds. Greenfield capacity is projected to rise from 1,100 beds in March 2026 to 2,250 beds by December 2028, while expansions add 450 beds.
The next disclosed milestones are Mehar Hospital’s first-week-of-December 2026 commissioning and the Q4 FY’27 openings of Park Platinum, Febris Hospital and Kanpur. Management’s subsequent schedule includes Gorakhpur in April 2027, Mohali and Ambala expansions in September and October 2027, Rohtak in January 2028, and the 550-bed Prayagraj lease project in December 2028.


